You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. 2-5A Antisense Targeting of Telomerase RNA

    SBC: RIDGEWAY BIOSYSTEMS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The ribonucleoprotein complex telomerase has been implicated in the establishment and progression of many different types of tumors. Telomerase activity is detected in roughly 80 percent of all tumor cell types, but is absent in most normal cells. Thus, the disruption of telomerase activity is a particularly attractive means for treating multiple types of cance ...

    STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  2. Advanced Optical Diagnostics/Modeling Platform for Plasma Assisted Combustion in Vitiated Air

    SBC: SPECTRAL ENERGIES LLC            Topic: AF13AT04

    ABSTRACT: Modern gas-turbine engines designs for the next-generation warfighter need to reduce exhaust gas temperatures to reduce effective thermal footprint thereby improving the mission capability. In such situations, high-altitude engine operation is often limited by the overall combustion efficiency, lean flame blow out (LBO) limit, and combustion instabilities that results in narrower opera ...

    STTR Phase I 2014 Department of DefenseAir Force
  3. A FAP-Activated Proteasome Inhibitor for Killing Solid Tumors

    SBC: ARISAPH PHARMACEUTICALS, INC.            Topic: 102

    DESCRIPTION provided by applicant Cancer is the second leading cause of death after heart disease in the US Chemotherapy is a mainstay of treatment after surgical removal of tumors but the balance of clinical benefit versus disabling or life threatening side effects is often uncertain Genotyping of cancers to identify mutated oncogenes has enabled an era of targeted therapy Drugs targeting ...

    STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  4. A Multivalent Lyme Disease Vaccine Targeting Tick-Host-Pathogen Interactions

    SBC: L2 DIAGNOSTICS LLC            Topic: NIAID

    DESCRIPTION provided by applicant This proposal seeks to develop a novel vaccine against Lyme disease by targeting Ixodes scapularis proteins critical for Borrelia burgdorferi transmission from the tick to mammalian host Earlier work has identified four tick proteins Salp TRE tHRF and TSLPI that facilitate different steps of spirochete transmission and immunity against these protein ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  5. An Equilibrated Micromachined Pressure (EMP) Sensor for Hypersonic Transients

    SBC: RESEARCH SUPPORT INSTRUMENTS, INC.            Topic: N/A

    Research Support Instruments, Inc. (RSI), with the aid of Princeton University, proposes to develop an Equilibrated Micromachined Pressure (EMP) sensor for measuring hypersonic transients with amplitudes < 1 Torr and frequencies of hundreds of kHz.Existing micromachined transducers include capacitive, resistive, or optical techniques. Transducers using silicon membranes and piezoresistive or capa ...

    STTR Phase I 2003 Department of DefenseAir Force
  6. A New Chloride Sweat Test for Cystic Fibrosis Screening

    SBC: PolyChrome Medical, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): The CF Quantum(r) sweat test system is a rapid, easily administered, cost effective method to diagnose cystic fibrosis (CF). The CF Quantum(r) patch (Q-patch) uses an ion-exchange reaction to produce a white precipitate which varies in size based on the chloride ion concentration of the sweat sample. Reacting the Q-patch with a chloride-containing solution (i.e ...

    STTR Phase II 2003 Department of Health and Human ServicesNational Institutes of Health
  7. A New Chloride Sweat Test for Cystic Fibrosis Screening

    SBC: PolyChrome Medical, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): The CF Quantum(r) sweat test system is a rapid, easily administered, cost effective method to diagnose cystic fibrosis (CF). The CF Quantum(r) patch (Q-patch) uses an ion-exchange reaction to produce a white precipitate which varies in size based on the chloride ion concentration of the sweat sample. Reacting the Q-patch with a chloride-containing solution (i.e ...

    STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  8. A novel Approach for High Rate Production of IR to IR Up-converting Nano-particles

    SBC: UES INC            Topic: AF11BT24

    ABSTRACT: Phosphor materials are currently being utilized in a wide variety of applications. The requirements for phosphors have become more and more stringent with smaller and smaller particles being required. In the Phase I program UES Inc. in collaboration with Penn State University has demonstrated the feasibility of a few approaches for high rate production of high efficiency IR to IR up-con ...

    STTR Phase II 2014 Department of DefenseAir Force
  9. A novel platelet inhibitor from bloodfeeding hookworms

    SBC: L2 DIAGNOSTICS LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Thromboembolic disease is a major cause of morbidity and mortality in the developed world. Because platelets play a critical role in the activation and propagation of thrombosis, they represent important targets for new anti-thrombotic drugs. A potent inhibitor of human platelet function has been isolated from the bloodfeeding hookworm, Ancylostoma caninum. ...

    STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  10. Application of Cortical Processing Theory to Acoustical Analysis

    SBC: SENSIMETRICS CORP            Topic: N/A

    This research proposal aims at formulating signal processing principles realized by the auditory system, in particular when the input signal is speech. Two specific aims are: (1) to model the role of the descending pathway in stabilizing AN representationsof speech sounds in degraded acoustic conditions. Current models of the auditory periphery are based upon the ascending pathway up through the A ...

    STTR Phase I 2003 Department of DefenseAir Force
US Flag An Official Website of the United States Government